Within the partitions of the Hospital Clínic of Barcelona, in a spherical journey by not more than three corridors and some stairs, an modern immunotherapy in opposition to most cancers is deliberate, manufactured and administered that has modified the prognosis of some blood tumors: it’s CAR-T remedy, a piece of genetic engineering that retrains the affected person’s immune system to raised struggle malignant cells. There are already a handful of medicines of this kind manufactured by the pharmaceutical trade, however the Clínic has been a pioneer within the improvement of an educational CAR-T with which they’ve already handled greater than 650 sufferers with out therapeutic alternate options. “We went from treating seven patients in 2017 to 114 in 2025. It is a revolution and I do not see a limit,” says hematologist Julio Delgado, head of the Oncoimmunotherapy Unit. “There are more and more indications, more clinical trials… And the beautiful thing is that, since we do it, we set the limit ourselves, we do not depend on the pharmaceutical industry to do it,” he emphasizes.
Continue studying
https://elpais.com/salud-y-bienestar/2026-04-28/en-las-cocinas-de-los-car-t-la-innovadora-inmunoterapia-contra-el-cancer-es-una-revolucion.html